Drawing for SELARREST

USPTO serial 76250128

SELARREST

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
KIM, YONG OH
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SELARREST?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Camille M. Miller

CAMILLE M MILLER COZEN O'CONNOR PC1900 MARKET STPHILADELPHIA, PA 19103UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical preparations, namely, cytokine inhibitory drugsABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 17, 2006ABN5ABANDONMENT - AFTER PUBLICATION—
Nov 17, 2006EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Jun 16, 2005COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 31, 2005EX5GSOU EXTENSION 5 GRANTED—
Mar 7, 2005EXT5SOU EXTENSION 5 FILED—
Mar 7, 2005EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 3, 2004EX4GSOU EXTENSION 4 GRANTED—
Aug 3, 2004EXT4SOU EXTENSION 4 FILED—
Aug 3, 2004EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 29, 2004CFITCASE FILE IN TICRS—
Feb 13, 2004EX3GSOU EXTENSION 3 GRANTED—
Jan 26, 2004EXT3SOU EXTENSION 3 FILED—
Jan 26, 2004EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 9, 2003EX2GSOU EXTENSION 2 GRANTED—
Aug 29, 2003EXT2SOU EXTENSION 2 FILED—
Aug 29, 2003EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 3, 2003EX1GSOU EXTENSION 1 GRANTED—
Dec 28, 2002EXT1SOU EXTENSION 1 FILED—
Dec 28, 2002EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 10, 2002NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 24, 2002MAILPAPER RECEIVED—
Dec 3, 2001ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Oct 30, 2001PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 10, 2001NPUBNOTICE OF PUBLICATION—
Sep 10, 2001CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 27, 2001DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance